Ivuxolimab, previously known as PF-04518600, represents a novel therapeutic approach as a precise PD-1 antagonist of the IgG1 isotype. Studies suggest that this molecule holds significant potential for https://ivuxolimab-t-cell-costim390862.wikiannouncement.com/user